Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 14.68 USD -2.13% Market Closed
Market Cap: 1B USD
Have any thoughts about
Bicycle Therapeutics PLC?
Write Note

Intrinsic Value

BCYC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one BCYC stock under the Base Case scenario is 9.02 USD. Compared to the current market price of 14.68 USD, Bicycle Therapeutics PLC is Overvalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BCYC Intrinsic Value
9.02 USD
Overvaluation 39%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Bicycle Therapeutics PLC

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for BCYC cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about BCYC?
Bearish
Neutral
Bullish

Fundamental Analysis

14.68 USD
-2.13%
-2.13%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Bicycle Therapeutics PLC
UK
Biotechnology
Market Cap
1B USD
IPO
May 23, 2019
Employees
119
United Kingdom
Market Cap
1B USD
Industry
Biotechnology
IPO
May 23, 2019
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Bicycle Therapeutics PLC

Provide an overview of the primary business activities
of Bicycle Therapeutics PLC.

What unique competitive advantages
does Bicycle Therapeutics PLC hold over its rivals?

What risks and challenges
does Bicycle Therapeutics PLC face in the near future?

Has there been any significant insider trading activity
in Bicycle Therapeutics PLC recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bicycle Therapeutics PLC.

Provide P/S
for Bicycle Therapeutics PLC.

Provide P/E
for Bicycle Therapeutics PLC.

Provide P/OCF
for Bicycle Therapeutics PLC.

Provide P/FCFE
for Bicycle Therapeutics PLC.

Provide P/B
for Bicycle Therapeutics PLC.

Provide EV/S
for Bicycle Therapeutics PLC.

Provide EV/GP
for Bicycle Therapeutics PLC.

Provide EV/EBITDA
for Bicycle Therapeutics PLC.

Provide EV/EBIT
for Bicycle Therapeutics PLC.

Provide EV/OCF
for Bicycle Therapeutics PLC.

Provide EV/FCFF
for Bicycle Therapeutics PLC.

Provide EV/IC
for Bicycle Therapeutics PLC.

Show me price targets
for Bicycle Therapeutics PLC made by professional analysts.

What are the Revenue projections
for Bicycle Therapeutics PLC?

How accurate were the past Revenue estimates
for Bicycle Therapeutics PLC?

What are the Net Income projections
for Bicycle Therapeutics PLC?

How accurate were the past Net Income estimates
for Bicycle Therapeutics PLC?

What are the EPS projections
for Bicycle Therapeutics PLC?

How accurate were the past EPS estimates
for Bicycle Therapeutics PLC?

What are the EBIT projections
for Bicycle Therapeutics PLC?

How accurate were the past EBIT estimates
for Bicycle Therapeutics PLC?

Compare the revenue forecasts
for Bicycle Therapeutics PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bicycle Therapeutics PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bicycle Therapeutics PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bicycle Therapeutics PLC compared to its peers.

Compare the P/E ratios
of Bicycle Therapeutics PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Bicycle Therapeutics PLC with its peers.

Analyze the financial leverage
of Bicycle Therapeutics PLC compared to its main competitors.

Show all profitability ratios
for Bicycle Therapeutics PLC.

Provide ROE
for Bicycle Therapeutics PLC.

Provide ROA
for Bicycle Therapeutics PLC.

Provide ROIC
for Bicycle Therapeutics PLC.

Provide ROCE
for Bicycle Therapeutics PLC.

Provide Gross Margin
for Bicycle Therapeutics PLC.

Provide Operating Margin
for Bicycle Therapeutics PLC.

Provide Net Margin
for Bicycle Therapeutics PLC.

Provide FCF Margin
for Bicycle Therapeutics PLC.

Show all solvency ratios
for Bicycle Therapeutics PLC.

Provide D/E Ratio
for Bicycle Therapeutics PLC.

Provide D/A Ratio
for Bicycle Therapeutics PLC.

Provide Interest Coverage Ratio
for Bicycle Therapeutics PLC.

Provide Altman Z-Score Ratio
for Bicycle Therapeutics PLC.

Provide Quick Ratio
for Bicycle Therapeutics PLC.

Provide Current Ratio
for Bicycle Therapeutics PLC.

Provide Cash Ratio
for Bicycle Therapeutics PLC.

What is the historical Revenue growth
over the last 5 years for Bicycle Therapeutics PLC?

What is the historical Net Income growth
over the last 5 years for Bicycle Therapeutics PLC?

What is the current Free Cash Flow
of Bicycle Therapeutics PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bicycle Therapeutics PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bicycle Therapeutics PLC

Current Assets 966.2m
Cash & Short-Term Investments 890.9m
Receivables 58m
Other Current Assets 17.4m
Non-Current Assets 30.6m
PP&E 20.6m
Other Non-Current Assets 9.9m
Current Liabilities 56.4m
Accounts Payable 5.7m
Accrued Liabilities 38.7m
Other Current Liabilities 12m
Non-Current Liabilities 109.3m
Other Non-Current Liabilities 109.3m
Efficiency

Earnings Waterfall
Bicycle Therapeutics PLC

Revenue
36.9m USD
Operating Expenses
-233.4m USD
Operating Income
-196.5m USD
Other Expenses
30.2m USD
Net Income
-166.3m USD

Free Cash Flow Analysis
Bicycle Therapeutics PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BCYC Profitability Score
Profitability Due Diligence

Bicycle Therapeutics PLC's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROE is Increasing
ROIC is Increasing
Exceptional Revenue Growth Forecast
30/100
Profitability
Score

Bicycle Therapeutics PLC's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

BCYC Solvency Score
Solvency Due Diligence

Bicycle Therapeutics PLC's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
High Altman Z-Score
65/100
Solvency
Score

Bicycle Therapeutics PLC's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BCYC Price Targets Summary
Bicycle Therapeutics PLC

Wall Street analysts forecast BCYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCYC is 38.76 USD with a low forecast of 25.25 USD and a high forecast of 57.75 USD.

Lowest
Price Target
25.25 USD
72% Upside
Average
Price Target
38.76 USD
164% Upside
Highest
Price Target
57.75 USD
293% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BCYC?

Click here to dive deeper.

Dividends

Bicycle Therapeutics PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for BCYC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BCYC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one BCYC stock?

The intrinsic value of one BCYC stock under the Base Case scenario is 9.02 USD.

Is BCYC stock undervalued or overvalued?

Compared to the current market price of 14.68 USD, Bicycle Therapeutics PLC is Overvalued by 39%.

Back to Top